Thank you for the question. The company was required, by the ASX, to notify the market of the announcement of the new deal with BioHealth and to inform shareholders about the variation of agreement with Medcan - 8th of February (Strategic Alliance ann & Prospectus #11). The deal will require shareholder approval at an EGM. (Prospectus #12)
Changes are simply ordered in a logical and chronological progression. This is the way that it must be presented.
The company accounts will be presented in the next Financial statement to the market.
Cheers,
Neil1959
CGB Price at posting:
3.7¢ Sentiment: None Disclosure: Held
